These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11423883)

  • 1. Monocyte tissue factor levels in cancer patients.
    Lwaleed BA; Francis JL; Chisholm M
    Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary tissue factor levels in patients with bladder and prostate cancer.
    Lwaleed BA; Francis JL; Chisholm M
    Eur J Surg Oncol; 2000 Feb; 26(1):44-9. PubMed ID: 10718179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of measuring monocyte tissue factor activity in patients with breast and colorectal cancer.
    Lwaleed BA; Chisholm M; Francis JL
    Br J Cancer; 1999 Apr; 80(1-2):279-85. PubMed ID: 10390009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary tissue factor levels in patients with breast and colorectal cancer.
    Lwaleed BA; Chisholm M; Francis JL
    J Pathol; 1999 Feb; 187(3):291-4. PubMed ID: 10398081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor assays as diagnostic tools for cancer? Correlation between urinary and monocyte tissue factor activity.
    Lwaleed BA; Francis JL; Chisholm M
    J Hematother Stem Cell Res; 1999 Dec; 8(6):659-68. PubMed ID: 10645774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
    Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
    Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocytes and plasma tissue factor levels in normal individuals and patients with deep venous thrombosis of the lower limbs: potential diagnostic tools?
    Vieira LM; Dusse LM; Fernandes AP; Martins-Filho OA; de Bastos M; Ferreira MF; Cooper AJ; Lwaleed BA; Carvalho MG
    Thromb Res; 2007; 119(2):157-65. PubMed ID: 16527335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte tissue factor levels in patients with urological tumours: an association between tumour presence and progression.
    Lwaleed BA; Francis JL; Chisholm M
    BJU Int; 1999 Mar; 83(4):476-82. PubMed ID: 10210574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procoagulant activity in whole blood from patients with breast and colorectal cancer.
    Parmar J; Taylor I; Roath S; Francis J
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):127-32. PubMed ID: 2130924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte release and plasma levels of interleukin-6 in patients irradiated for cancer.
    Petrini B; Andersson B; Strannegard O; Wasserman J; Blomgren H; Glas U
    In Vivo; 1992; 6(5):531-4. PubMed ID: 1457747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
    Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
    Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer.
    Yasuda K; Nagakawa O; Akashi T; Fujiuchi Y; Koizumi K; Komiya A; Saiki I; Fuse H
    Prostate; 2009 Mar; 69(4):346-51. PubMed ID: 19021204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of some trace elements concentration in blood, tumor free breast and tumor tissues of women with benign and malignant breast lesions: an Indian study.
    Siddiqui MK; Jyoti ; Singh S; Mehrotra PK; Singh K; Sarangi R
    Environ Int; 2006 Jul; 32(5):630-7. PubMed ID: 16580070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
    Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
    J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.
    Coskun U; Bukan N; Sancak B; Günel N; Ozenirler S; Unal A; Yucel A
    Neoplasma; 2004; 51(3):209-13. PubMed ID: 15254675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases.
    Selander KS; Brown DA; Sequeiros GB; Hunter M; Desmond R; Parpala T; Risteli J; Breit SN; Jukkola-Vuorinen A
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):532-7. PubMed ID: 17372249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
    Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
    J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.